Scancell HoldingsSCNLF 20 Market Cap is $251.81 Mil as of Jun. 27, 2026. GuruFocus rates SCNLF with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 1,431 Biotechnology companies, Scancell Holdings ranks better than 62.12% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Scancell Holdings's share price for the quarter that ended in Oct. 2025 was $0.1191. Scancell Holdings's Shares Outstanding (EOP) for the quarter that ended in Oct. 2025 was 1,037.78 Mil. Therefore, Scancell Holdings's market cap for the quarter that ended in Oct. 2025 was $123.60 Mil.
Scancell Holdings's quarterly market cap
declined
from Oct. 2024 ($199.40 Mil) to Apr. 2025 ($176.05 Mil) and
declined
from Apr. 2025 ($176.05 Mil) to Oct. 2025 ($123.60 Mil).
Scancell Holdings's annual market cap
declined
from Apr. 2023 ($180.23 Mil) to Apr. 2024 ($117.98 Mil) but then
increased
from Apr. 2024 ($117.98 Mil) to Apr. 2025 ($176.05 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Scancell Holdings's Enterprise Value for Today is $269.58 Mil.
Scancell Holdings (OTCPK:SCNLF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Scancell Holdings Market Cap Related Terms
Scancell Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for Scancell Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Scancell Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scancell Holdings Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Scancell Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Scancell Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Scancell Holdings's Market Cap for the fiscal year that ended in Apr. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scancell Holdings (SCNLF) has a Market Cap of $251.81 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Scancell Holdings and its competitors. According to the industry distribution chart, Scancell Holdings ranks #542 out of 1431 companies in the Biotechnology industry, placing it in the top 37.9%.
Is Scancell Holdings' Market Cap too high?
Scancell Holdings' current Market Cap is $251.81 Mil. The Biotechnology industry median Market Cap is 113.83. Scancell Holdings' value of $251.81 Mil is 121.2% above this industry median. Based on the distribution chart, Scancell Holdings ranks #542 out of 1431 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Scancell Holdings has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Scancell Holdings' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Scancell Holdings ranks #542 out of 1431 companies for Market Cap. This puts Scancell Holdings in the upper half of its industry. The industry median Market Cap is 113.83. Scancell Holdings' value of $251.81 Mil is 121.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scancell Holdings's current Market Cap of $251.81 Mil is 121.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Scancell Holdings and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scancell Holdings's current Market Cap is $251.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scancell Holdings stock overvalued right now?
Scancell Holdings (SCNLF) has a current Market Cap of $251.81 Mil. The current Market Cap is $251.81 Mil and 121.2% above the Biotechnology industry median of 113.83. Scancell Holdings' overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Scancell Holdings (SCNLF), the current Market Cap is $251.81 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Scancell Holdings PLC is a clinical-stage biotechnology company developing targeted off-the-shelf active immunotherapies to generate safe and long-lasting tumour-specific immunity for a cancer-free future. iSCIB1+, a product from its DNA ImmunoBody platform (AvidiMab), has demonstrated safe, durable, and clinically meaningful benefit as a monotherapy as well as additional benefit when combined with checkpoint therapies in an ongoing Phase 2 trial in melanoma. Modi-1, the peptide immunotherapy from its Moditope platform, is being investigated in a Phase 2 study in a broad range of solid tumours. In addition, the company has established a subsidiary with the intention to hold and develop an early-stage pipeline of high-affinity GlyMab antibodies targeting tumour-specific glycans.
20GF Score
Get the complete analysis for SCNLF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SCNLF has been successfully added to your 
